Technical Trend Overview
Suraksha Diagnostic Ltd’s technical trend has recently transitioned from a clear bearish outlook to a mildly bearish one, indicating a tentative easing of downward pressure. The stock closed at ₹257.55 on 21 Jul 2026, down marginally by 0.44% from the previous close of ₹258.70. The intraday range was narrow, with a low of ₹257.00 and a high of ₹259.95, suggesting limited volatility on the day.
Over the past 52 weeks, the stock has traded between ₹224.10 and ₹333.65, currently sitting closer to the lower end of this range. This positioning highlights the stock’s struggle to regain momentum amid a challenging market environment.
MACD and RSI Signals
The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly timeframe, signalling that the stock’s short-term momentum is still under pressure. The monthly MACD, however, does not currently provide a definitive signal, reflecting a lack of clear directional momentum over the longer term.
Conversely, the Relative Strength Index (RSI) on the weekly chart has turned bullish, suggesting some short-term buying interest and potential for a modest rebound. The monthly RSI remains neutral with no clear signal, indicating that the stock is neither overbought nor oversold on a longer horizon.
Moving Averages and Bollinger Bands
Daily moving averages continue to show a bearish trend, with the stock price trading below key averages, reinforcing the downward momentum. This bearish alignment of moving averages typically acts as resistance, making it difficult for the stock to mount a sustained rally without a significant catalyst.
Bollinger Bands on the weekly chart also reflect bearish conditions, with the price hugging the lower band, which often signals persistent selling pressure. On the monthly scale, the bands are moving sideways, indicating a consolidation phase without a clear directional bias.
Additional Technical Indicators
The Know Sure Thing (KST) oscillator on the weekly timeframe is mildly bearish, aligning with the broader technical trend shift. Dow Theory analysis on the weekly chart also supports a mildly bearish outlook, while the monthly Dow Theory shows no definitive trend, underscoring the stock’s uncertain medium-term direction.
On-Balance Volume (OBV) analysis reveals no clear trend on the weekly chart, but a mildly bearish signal on the monthly timeframe, suggesting that volume flows are not strongly supporting any upward price movement.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
Comparative Performance and Market Context
Suraksha Diagnostic Ltd’s recent returns have lagged behind the broader Sensex benchmark. Over the past week, the stock declined by 1.44%, while the Sensex gained 0.12%. The one-month return for Suraksha Diagnostic was down 3.85%, contrasting with a 1.18% rise in the Sensex. Year-to-date, the stock is down 3.97%, whereas the Sensex has fallen more sharply by 8.81%, indicating some relative resilience in the stock despite negative absolute returns.
However, the one-year performance paints a less favourable picture, with Suraksha Diagnostic declining 19.26% compared to a 4.95% drop in the Sensex. This underperformance over the medium term highlights the stock’s challenges amid sectoral and company-specific headwinds.
Mojo Score and Ratings Update
MarketsMOJO assigns Suraksha Diagnostic Ltd a Mojo Score of 41.0, categorising it as a Sell. This represents a downgrade from the previous Hold rating as of 1 Jun 2026, reflecting deteriorating technical and fundamental conditions. The company’s micro-cap status adds to the risk profile, with limited liquidity and higher volatility compared to larger peers in the Healthcare Services sector.
Outlook and Investor Considerations
While some short-term technical indicators such as the weekly RSI suggest potential for modest recovery, the overall technical landscape remains cautious. The persistent bearish signals from MACD, moving averages, and Bollinger Bands imply that the stock may face resistance in regaining upward momentum without positive fundamental developments or sector tailwinds.
Investors should weigh the stock’s current technical signals against its relative underperformance and micro-cap risks. The mildly bearish trend shift may offer a window for tactical trades, but a sustained turnaround would require confirmation from stronger volume support and a break above key moving averages.
Suraksha Diagnostic Ltd or something better? Our SwitchER feature analyzes this micro-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary
Suraksha Diagnostic Ltd’s technical parameters reveal a nuanced picture. The shift from bearish to mildly bearish suggests some easing of selling pressure, yet the dominant signals remain cautious. Weekly MACD and daily moving averages continue to weigh on the stock, while weekly RSI offers a glimmer of short-term optimism. The stock’s relative underperformance versus the Sensex and its micro-cap classification further complicate the outlook.
For investors, the current technical setup advises prudence. Monitoring volume trends and key moving average breaks will be critical to identifying any sustainable momentum shifts. Until then, the stock remains a speculative proposition within the Healthcare Services sector.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
